Pablo Legorreta

Founder, Chief Executive Officer & Chairman
Royalty Pharma

Pablo is the founder, CEO and Chairman of Royalty Pharma (Nasdaq: RPRX). Since its founding in 1996, Royalty Pharma has been the pioneer and market leader in royalty funding of life science innovation. The company’s collaborations span the entire research and development ecosystem, from academic institutions, research hospitals and not-for-profits to small- and mid-cap biotechnology companies and global pharmaceutical companies. To date, Royalty Pharma has deployed more than $35 billion of capital to advance innovation in the biopharmaceutical industry.

Pablo co-founded Pharmakon Advisors in 2009, which has become the premier provider of debt capital to the life sciences industry, with assets under management (AUM) of over $6 billion. In 2017, Pablo launched BioPharma Credit PLC, the first London Stock Exchange listed fund (LSE: BPCR) specializing in debt financing for the life sciences industry. Pablo is also a co-founder of several biotech companies: ProKidney (Nasdaq: PROK), an autologous cell therapy to treat chronic kidney disease; Sequel Med-tech, a novel pump for type-1 diabetes and drug delivery at nano-scale precision; ITB-MED, focused in modernizing immunosuppressive treatments in solid organ transplants; xenotransplantation company ChoironeX, which owns a colony of highly inbred miniature swine for organs for humans; and POD, a normothermic organ perfusion device.

Pablo is also the founder and Chairman of Alianza Médica para la Salud, a non-profit dedicated to enhancing the quality of health care in Latin America by providing doctors and healthcare providers with scholarships for continuing education opportunities in Mexico and abroad in partnership with the Open Medical Institute (OMI). Pablo serves on the Board of Governors of the New York Academy of Sciences, as well as the Boards of Trustees of Rockefeller University, the Hospital for Special Surgery, Pasteur Foundation (US), the OMI and Park Avenue Armory. Pablo and his wife Almudena created the Legorreta Center for Clinical Transplant Tolerance at MGH and the Legorreta Cancer Center at Brown University.

Prior to founding Royalty Pharma, Pablo was an investment banker at Lazard Frères in Paris and New York from 1987 to 1996.